Sohini Das And Arnab Dutta

Stories by Sohini Das And Arnab Dutta

Private hospitals may import Covid vaccines

Private hospitals may import Covid vaccines

Rediff.com   15 May 2021

Apollo Hospitals and Fortis Healthcare are open to importing vaccines.

Apple takes a big bite out of locked down India, posts record JFM sales

Apple takes a big bite out of locked down India, posts record JFM sales

Rediff.com   14 May 2021

Apple was a fringe player in all key categories like smartphones, notebooks, and tablets till recently. But with the last quarter's record-breaking performance, the brand has established itself in the country's price-sensitive consumer electronics market.

Mobile phone production down 50% amid Covid-19 surge

Mobile phone production down 50% amid Covid-19 surge

Rediff.com   12 May 2021

According to research firm IDC, a slowdown in smartphone shipments began showing up as early as late February, though companies insist that the March quarter was fine, albeit on a low base.

Prices of key Covid bulk drugs shoot up as demand rises

Prices of key Covid bulk drugs shoot up as demand rises

Rediff.com   12 May 2021

The API of Paracetamol, a fever and pain medication, has grown 25 per cent from Rs 450-480 per kg in December 2020 to Rs 580-600 per kg in April. When compared to the pre-Covid prices of December 2019, the surge is much steeper -- around 140 per cent, reports Sohini Das.

With Covid surge, FabiFlu becomes most sold drug in India

With Covid surge, FabiFlu becomes most sold drug in India

Rediff.com   11 May 2021

Drugs that are used to treat Covid or used by people as immunity boosters have seen a jump in sales and, in turn, rankings.

COVID-19 second wave: Delays in RT-PCR tests

COVID-19 second wave: Delays in RT-PCR tests

Rediff.com   9 May 2021

While there is a shortage of testing kits, manpower and capacities, India does not have other scalable testing options.

'No preparedness planning, no accountability, no action plan'

'No preparedness planning, no accountability, no action plan'

Rediff.com   8 May 2021

'This government did not have any plan for safety stocks of essential medicines.'

Pharma industry posts 51.5% growth in April sales

Pharma industry posts 51.5% growth in April sales

Rediff.com   8 May 2021

When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent.

Remdesivir black-market thrives as Covid cases rise

Remdesivir black-market thrives as Covid cases rise

Rediff.com   6 May 2021

Artificial shortages and brazen hawking of the drug on the streets at 15 times the normal price rule the day as the official machinery tries desperately to stamp out the parallel market, reports Sohini Das

Gujarat gets lion's share of Covid vaccines

Gujarat gets lion's share of Covid vaccines

Rediff.com   4 May 2021

Delhi, which has been one of the worst affected states, accounted for less than two per cent of total vaccinations in the 18-44 age-group.

Covid vaccine: Too early to say if booster dose needed

Covid vaccine: Too early to say if booster dose needed

Rediff.com   30 Apr 2021

Initial data has shown immunity triggered by the two mRNA vaccines -- Pfizer-BioNTech and Moderna -- lasts for at least six months

2nd Covid wave may erase gains in smartphone market

2nd Covid wave may erase gains in smartphone market

Rediff.com   28 Apr 2021

While the record shipments reflects the prevailing mood at the time, the exponential rise in Covid cases in the country has turned the tide since.

Covid vaccine could cost up to Rs 1000 in private market

Covid vaccine could cost up to Rs 1000 in private market

Rediff.com   28 Apr 2021

While the Indian government has been procuring Covid-19 vaccines at low prices so far, manufacturers have to declare the prices of vaccines they would supply to the open market (industries, private hospitals, etc) and state governments before May 1. Sohini Das reports.

A COVID-19 Vaccine Snapshot

A COVID-19 Vaccine Snapshot

Rediff.com   28 Apr 2021

Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria.

Where is the manpower to handle ventilators?

Where is the manpower to handle ventilators?

Rediff.com   25 Apr 2021

The second wave of the pandemic has not only crippled medical infrastructure in terms of hospital beds, but has also led to bottlenecks in invasive ventilators and medical oxygen capacities and supplies.

Demand for Covid-19 tests growing 100 pc week-on-week

Demand for Covid-19 tests growing 100 pc week-on-week

Rediff.com   23 Apr 2021

One challenge for many laboratories in ramping up is the shortage of trained manpower for collecting samples, report Sohini Das, Vinay Umarji and Virendra Singh Rawat.

Delhi curfew, oxygen shortage takes a toll on Noida industrial belt

Delhi curfew, oxygen shortage takes a toll on Noida industrial belt

Rediff.com   23 Apr 2021

From trucks lined up and waiting in the area to local vendors, the scenes tell a story of livelihoods stalled.

Shortage of key chemical from US hits Covaxin ramp-up plans

Shortage of key chemical from US hits Covaxin ramp-up plans

Rediff.com   22 Apr 2021

'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'

Apple revs up India offering with new iMac, iPads and iPhone

Apple revs up India offering with new iMac, iPads and iPhone

Rediff.com   22 Apr 2021

The new iMac, two iPads and iPhone 12 and 12 Mini will be open for ordering starting April 30, just like in the US, the UK, China and Japan.

Serum, Bharat Biotech to get Rs 45 bn for 300 mn vaccines

Serum, Bharat Biotech to get Rs 45 bn for 300 mn vaccines

Rediff.com   20 Apr 2021

This will be an upfront payment for the vaccine doses that these two companies will supply to the government.